The Microbiome and Cancer Treatment Overcoming Resistance and Enhancing Efficacy

Garima Malik has completed her B. Pharmacy from Vaish Institute of Pharmaceutical Education and Research, Rohtak, and an M.Pharmacy from Chandigarh College of Pharmacy, Landran. She has more than 3 years of experience as an Assistant Professor in the Department of Pharmaceutics. Currently, she is working as an Assistant Professor at M.M College of Pharmacy, Maharishi Markandeshwar University, Mullana, Ambala, India. Ms Garima had about 1.5 years of experience as an officer in the Quality control department at Zenacts Pharma Manimajra, Chandigarh. Her M.Pharmacy project focused on the topic of “Preparation and evaluation of Fusidic acid loaded transferosomes amalgamated with gel for the management of burn wound infection”. She has published more than 10 publications, including 1 Patent, and 5 book chapters. Her area of interest is nanotechnology, hydrogels, biomaterials, and their application in drug delivery.

Dr. Arun Kumar Singh is an assistant professor in the Department of Pharmacy at Vivekanand Global University, Jaipur. He completed both his MPharm in Pharmaceutics and his PhD at Galgotias University, Greater Noida. His research strengths lie in AI-driven cancer research, nano-formulation, and the intersection of blockchain, IoT, machine learning, big data, and neuroscience with pharmaceutical science. He has authored books and contributed chapters on big data and cancer, and his work includes reviews published in reputable journals. His research appears across publishers such as IOP, Elsevier, CRC Press, and Wiley, reflecting a broad publication record and ongoing contributions to AI-enabled oncology and advanced drug delivery.

Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with over 18 years of experience in pharmaceutical sciences. She holds a Master’s degree from NIPER Mohali and a Ph.D. from IIT-BHU Varanasi, specializing in medicinal chemistry and CNS drug delivery targeting 5HT1A/2A receptors. Dr. Dhanawat’s research spans synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, and herbal drug extraction. She has published 75 research articles and reviews, holds 5 patents, authored 6 books, contributed 13 book chapters, and edited 5 books. An active participant in national and international conferences, she has received prestigious grants from AAPS, DBT, and DST, along with the Rajiv Gandhi National Fellowship. Dr. Dhanawat’s work significantly advances pharmaceutical innovation and education, reflecting her commitment to scientific excellence and mentorship